Ai-Xue Liu
Affiliations: | Clinical Safety & Risk Management | Merck, Semoy, Centre-Val de Loire, France |
Google:
"Ai-Xue Liu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu AX, Zhang D, Zhu YM, et al. (2016) Impact of axis of GHRH and GHRH receptor on cell viability and apoptosis of the placental choriocarcinoma cell line. Current Molecular Medicine |
| Gao HJ, Zhu YM, He WH, et al. (2012) Endoplasmic reticulum stress induced by oxidative stress in decidual cells: A possible mechanism of early pregnancy loss Molecular Biology Reports. 39: 9179-9186 |
| Zou LB, Zhang RJ, Tan YJ, et al. (2011) Identification of estrogen response element in the aquaporin-2 gene that mediates estrogen-induced cell migration and invasion in human endometrial carcinoma. The Journal of Clinical Endocrinology and Metabolism. 96: E1399-408 |
| Chan G, Cheung LS, Yang W, et al. (2011) Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood. 117: 4253-61 |
| Kamasani U, Liu AX, Prendergast GC. (2003) Genetic response to farnesyltransferase inhibitors: proapoptotic targets of RhoB. Cancer Biology & Therapy. 2: 273-80 |
| DuHadaway JB, Du W, Donover S, et al. (2003) Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. Oncogene. 22: 3578-88 |
| Liu AX, Rane N, Liu JP, et al. (2001) RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Molecular and Cellular Biology. 21: 6906-12 |
| Liu A, Prendergast GC. (2000) Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors. Febs Letters. 481: 205-8 |
| Liu Ax, Du W, Liu JP, et al. (2000) RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Molecular and Cellular Biology. 20: 6105-13 |
| Liu AX, Testa JR, Hamilton TC, et al. (1998) AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Research. 58: 2973-7 |